Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
Background: The double-blind, 2 × 2 factorial design, placebo-controlled ASCEND randomized trial compared the effects of 100 mg aspirin daily and, separately, 1 g omega-3 fatty acids (FAs) daily on the primary prevention of cardiovascular disease in 15,480 UK adults with diabetes. We report the effe...
Main Authors: | Sammons, EL, Buck, G, Bowman, LJ, Stevens, WM, Hammami, I, Parish, S, Armitage, J |
---|---|
Format: | Journal article |
Sprog: | English |
Udgivet: |
BioMed Central
2024
|
Lignende værker
-
Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
af: Sammons, EL, et al.
Udgivet: (2024) -
Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
af: Emily L. Sammons, et al.
Udgivet: (2024-11-01) -
ASCEND-Eye: effects of aspirin on diabetic retinopathy
af: Sammons, E, et al.
Udgivet: (2024) -
ASCEND-Eye: effects of omega-3 fatty acids on diabetic retinopathy
af: Sammons, E, et al.
Udgivet: (2023) -
ASCEND-eye: rationale, design and baseline characteristics for a sub-study of the ASCEND randomized trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
af: Sammons, E, et al.
Udgivet: (2023)